ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

174 Folgen

1. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Return to Play

   Vom: 5.7.2022
2. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Post-acute Sequelae

   Vom: 28.6.2022
3. ACCEL Lite: ACC Expert Consensus Decision Pathway on COVID-19: Myocarditis

   Vom: 21.6.2022
4. ACCEL Lite: Inflamed! Populations at Risk for Inflammation Associated CVD

   Vom: 14.6.2022
5. ACCEL Lite: Significant Updates from the 2021 ACC Coronary Artery Revascularization Guidelines

   Vom: 7.6.2022
6. ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR

   Vom: 24.5.2022
7. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Vom: 17.5.2022
8. ACCEL Lite: ACC.22 Late Breaker: CHAP RCT -- Antihypertensive Therapy For Mild Chronic Hypertension Improves Pregnancy Outcomes

   Vom: 10.5.2022
9. ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)

   Vom: 3.5.2022
10. ACCEL Lite: Late Breaker: Mavacamten as an Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Vom: 26.4.2022
11. ACCEL Lite: Late Breaker: SODIUM-HF: Dietary Intervention Under 100 Mmol In Heart Failure

    Vom: 19.4.2022
12. ACCEL Lite: Late Breaker: METEORIC-HF: The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic HFrEF

    Vom: 12.4.2022
13. ACCEL Lite: Late Breaker: DIAMOND trial: Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF

    Vom: 5.4.2022
14. ACCEL Lite: Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice

    Vom: 22.3.2022
15. ACCEL Lite: When Is Genetic Testing Helpful?

    Vom: 15.3.2022
16. ACCEL Lite: Special Considerations in Screening of Masters Athletes with CAD

    Vom: 8.3.2022
17. ACCEL Lite: Helping Patients Improve Lifestyle Behavior in the Digital Era

    Vom: 1.3.2022
18. ACCEL Lite: Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis--Focus on AL

    Vom: 22.2.2022
19. ACCEL Lite: What Should Optimal Medical Therapy Look Like Prior to Intervention?

    Vom: 15.2.2022
20. ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol

    Vom: 8.2.2022